TY - JOUR AU - Mavrakanas, T. AU - Bounameaux, H. PY - 2011 DA - 2011// TI - The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism JO - Pharmacol Ther VL - 130 UR - https://doi.org/10.1016/j.pharmthera.2010.12.007 DO - 10.1016/j.pharmthera.2010.12.007 ID - Mavrakanas2011 ER - TY - JOUR AU - Geerts, W. H. AU - Bergqvist, D. AU - Pineo, G. F. AU - Heit, J. A. AU - Samama, C. M. AU - Lassen, M. R. PY - 2008 DA - 2008// TI - Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) JO - Chest VL - 133 UR - https://doi.org/10.1378/chest.08-0656 DO - 10.1378/chest.08-0656 ID - Geerts2008 ER - TY - JOUR AU - Falck-Ytter, Y. AU - Francis, C. W. AU - Johanson, N. A. AU - Curley, C. AU - Dahl, O. E. AU - Schulman, S. PY - 2012 DA - 2012// TI - Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines JO - Chest VL - 141 UR - https://doi.org/10.1378/chest.11-2404 DO - 10.1378/chest.11-2404 ID - Falck-Ytter2012 ER - TY - JOUR PY - 2011 DA - 2011// TI - Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (JCS 2009) JO - Circ J VL - 75 UR - https://doi.org/10.1253/circj.CJ-88-0010 DO - 10.1253/circj.CJ-88-0010 ID - ref4 ER - TY - BOOK PY - 2008 DA - 2008// TI - Guidelines for Prevention of Venous Thromboembolism by the Japanese Orthopeaedic Association [in Japanse] PB - Nankodo Co., Ltd CY - Tokyo ID - ref5 ER - TY - JOUR AU - Fuji, T. AU - Ochi, T. AU - Niwa, S. AU - Fujita, S. PY - 2008 DA - 2008// TI - Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin JO - J Orthop Sci VL - 13 UR - https://doi.org/10.1007/s00776-008-1264-0 DO - 10.1007/s00776-008-1264-0 ID - Fuji2008 ER - TY - JOUR AU - Fuji, T. AU - Fujita, S. AU - Ochi, T. PY - 2008 DA - 2008// TI - Fondaparinux prevents venous thromboembolism after joint replacement surgery in Japanese patients JO - Int Orthop VL - 32 UR - https://doi.org/10.1007/s00264-007-0360-7 DO - 10.1007/s00264-007-0360-7 ID - Fuji2008 ER - TY - JOUR AU - Furugohri, T. AU - Isobe, K. AU - Honda, Y. AU - Kamisato-Matsumoto, C. AU - Sugiyama, N. AU - Nagahara, T. PY - 2008 DA - 2008// TI - DU-176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles JO - J Thromb Haemost VL - 6 ID - Furugohri2008 ER - TY - JOUR AU - Fuji, T. AU - Fujita, S. AU - Tachibana, S. AU - Kawai, Y. PY - 2010 DA - 2010// TI - A dose-ranging study evaluating the oral factor Xa inhibitor edoxaban for the prevention of venous thromboembolism in patients undergoing total knee arthroplasty JO - J Thromb Haemost VL - 8 UR - https://doi.org/10.1111/j.1538-7836.2010.04021.x DO - 10.1111/j.1538-7836.2010.04021.x ID - Fuji2010 ER - TY - JOUR AU - Raskob, G. AU - Cohen, A. T. AU - Eriksson, B. I. AU - Puskas, D. AU - Shi, M. AU - Bocanegra, T. PY - 2010 DA - 2010// TI - Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose–response study JO - Thromb Haemost VL - 104 UR - https://doi.org/10.1160/TH10-02-0142 DO - 10.1160/TH10-02-0142 ID - Raskob2010 ER - TY - JOUR AU - Fuji, T. AU - Wang, C. -. J. AU - Fujita, S. AU - Tachibana, S. AU - Kawai, Y. PY - 2009 DA - 2009// TI - Edoxaban in patients undergoing total hip arthroplasty: a phase IIb dose-finding study [Abstract] JO - Blood VL - 114 ID - Fuji2009 ER - TY - JOUR AU - Cockcroft, D. W. AU - Gault, M. H. PY - 1976 DA - 1976// TI - Prediction of creatinine clearance from serum creatinine JO - Nephron VL - 16 UR - https://doi.org/10.1159/000180580 DO - 10.1159/000180580 ID - Cockcroft1976 ER - TY - JOUR AU - Farrington, C. P. AU - Manning, G. PY - 1990 DA - 1990// TI - Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk JO - Stat Med VL - 9 UR - https://doi.org/10.1002/sim.4780091208 DO - 10.1002/sim.4780091208 ID - Farrington1990 ER - TY - BOOK PY - 2004 DA - 2004// TI - Japanese Guidelines for Prevention of Venous Thromboembolism [in Japanese] PB - Medical Front International Limited CY - (Ver.1) Tokyo ID - ref14 ER - TY - STD TI - Fuji T, Wang CJ, Fujita S, Kawai Y, Kimura T, Tachibana S. Safety and efficacy of edoxaban, an oral factor Xa inhibitor, for thromboprophylaxis after total hip arthroplasty in Japan and Taiwan. Thromb Res. 2014;134:1198–204. ID - ref15 ER - TY - JOUR AU - Nagase, Y. AU - Yasunaga, H. AU - Horiguchi, H. AU - Hashimoto, H. AU - Shoda, N. AU - Kadona, Y. PY - 2011 DA - 2011// TI - Risk factors for pulmonary embolism and the effects of fondaparinux after total hip and knee arthroplasty: a retrospective observational study with use of a national database in Japan JO - J Bone Joint Surg Am VL - 93 UR - https://doi.org/10.2106/JBJS.J.01365 DO - 10.2106/JBJS.J.01365 ID - Nagase2011 ER - TY - JOUR AU - Rohatagi, S. AU - Mendell, J. AU - Kastrissios, H. AU - Green, M. AU - Shi, M. AU - Patel, I. PY - 2012 DA - 2012// TI - Characterisation of exposure versus response of edoxaban in patients undergoing total hip replacement surgery JO - Thromb Haemost VL - 108 UR - https://doi.org/10.1160/TH12-03-0184 DO - 10.1160/TH12-03-0184 ID - Rohatagi2012 ER - TY - JOUR AU - Eriksson, B. I. AU - Rosencher, N. AU - Friedman, R. J. AU - Homering, M. AU - Dahl, O. E. PY - 2012 DA - 2012// TI - Concomitant use of medication with antiplatelet effects in patients receiving either rivaroxaban or enoxaparin after total hip or knee arthroplasty JO - Thromb Res VL - 130 UR - https://doi.org/10.1016/j.thromres.2011.12.005 DO - 10.1016/j.thromres.2011.12.005 ID - Eriksson2012 ER - TY - JOUR AU - Strebel, N. AU - Prins, M. AU - Agnelli, G. AU - Buller, H. R. PY - 2002 DA - 2002// TI - Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective surgery? JO - Arch Intern Med VL - 162 UR - https://doi.org/10.1001/archinte.162.13.1451 DO - 10.1001/archinte.162.13.1451 ID - Strebel2002 ER - TY - JOUR AU - Carlson, M. K. AU - Gleason, P. P. AU - Sen, S. PY - 2001 DA - 2001// TI - Elevation of hepatic transaminases after enoxaparin use: case report and review of unfractionated and low-molecular-weight heparin-induced hepatotoxicity JO - Pharmacotherapy VL - 21 UR - https://doi.org/10.1592/phco.21.1.108.34436 DO - 10.1592/phco.21.1.108.34436 ID - Carlson2001 ER - TY - JOUR AU - Eriksson, B. I. AU - Borris, L. C. AU - Friedman, R. J. AU - Haas, S. AU - Huisman, M. V. AU - Kakkar, A. K. PY - 2008 DA - 2008// TI - Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty JO - N Engl J Med VL - 358 UR - https://doi.org/10.1056/NEJMoa0800374 DO - 10.1056/NEJMoa0800374 ID - Eriksson2008 ER - TY - JOUR AU - Eriksson, B. I. AU - Dahl, O. E. AU - Rosencher, N. AU - Kurth, A. A. AU - Dijk, C. N. AU - Frostick, S. P. PY - 2007 DA - 2007// TI - Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial JO - Lancet VL - 370 UR - https://doi.org/10.1016/S0140-6736(07)61445-7 DO - 10.1016/S0140-6736(07)61445-7 ID - Eriksson2007 ER - TY - JOUR AU - Lassen, M. R. AU - Gallus, A. AU - Raskob, G. E. AU - Pineo, G. AU - Chen, D. AU - Ramirez, L. M. PY - 2010 DA - 2010// TI - ADVANCE-3 investigators. Apixaban versus enoxaparin for thromboprophylaxis after hip replacement JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa1006885 DO - 10.1056/NEJMoa1006885 ID - Lassen2010 ER - TY - STD TI - Lovenox® (enoxaparin sodium injection) for subcutaneous and intravenous use. [Package insert]. Sanofi-Aventis U.S. LLC, Bridgewater NJ. 2013. ID - ref24 ER -